Jupiter Neurosciences, Inc.
JUNS Nasdaq
SEC CIK 1679628
Follow Jupiter Neurosciences
Weekly email: filings, results
Revenue, last quarter
$13.9K
Net income
−$7.2M
−215.7% vs same quarter last year
EPS, diluted
−$7.42
Operating cash flow
−$2.7M
−135.6% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$8.6M |
| FY24 | −$2.4M |
| FY23 | −$4.8M |
| FY22 | - |